Shanghai Sunland Industrial Co., Ltd is the top manufacturer of Personal Protect Equipment in China, with 20 years’experience. We are the Chinese government appointed manufacturer for government power,personal protection equipment , medical instruments,construction industry, etc. All the products get the CE, ANSI and related Industry Certificates. All our safety helmets use the top-quality raw material without any recycling material.
Yuxi escape protective clothing manufacturer
We provide exclusive customization of the products logo, using advanced printing technology and technology, not suitable for fading, solid and firm, scratch-proof and anti-smashing, and suitable for various scenes such as construction, mining, warehouse, inspection, etc. Our goal is to satisfy your needs. Demand, do your best.
Professional team work and production line which can make nice quality in short time.
The professional team provides 24 * 7 after-sales service for you, which can help you solve any problems
Right now there is no vaccine available to protect against ,novel coronavirus,, but several versions of a vaccine are being tested to see if they work to prevent ,COVID-19, and are safe for humans. I was a close contact to a case of ,COVID-19, and was asked to self-quarantine.
Novel Coronavirus, (,COVID-19,) is a new strain of ,coronavirus, which may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases. First identified in a cluster with pneumonia symptoms in Wuhan city, Hubei province of China.
emerging enveloped viral pathogens and can be used during the current ,novel coronavirus, (,COVID-19,) outbreak. This product list is not exhaustive but can be used by business owners, health professionals, and the public to identify products suitable for use during the ,COVID-19, situation.
The 2019 ,novel coronavirus, (,COVID-19,, also known as 2019-nCoV) outbreak in Wuhan, China is rapidly approaching a pandemic as the number of countries with victims continues to grow. As of February 10, 2020, over 40,000 cases have been reported worldwide ( REF: WHO situation reports ).
Since ECDC’s fifth update on ,novel coronavirus, published on 2 March 2020 and as of 11 March, the number of cases and deaths reported in the EU/EEA and the UK has been rising, mirroring the trends seen in China in January-early February and in northern Italy in late February. If this trend continues, based on the quick pace of growth of the epidemic observed in China and northern Italy, it is ...
The antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine ,application, of serological testing in the diagnosis and management of ,COVID-19, patients.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al.; China ,Novel Coronavirus, Investigating and Research Team. A ,novel coronavirus, from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727 – 33. DOI PubMed